This "Stu's Views and MS News" e-Newsletter publication is an archive of our Bi-Monthly e-Publications. This archive began on JANUARY 1, 2009, when we were providing a weekly newsletter. Also on this page are Links and banners, redirecting you to many Benefitting resources including our Website, the MS Views and News YouTube Channel, our Blog and Blog Talk Radio and many other places. Register to receive our MS e-Newsletter by visiting our website. Join us on Facebook, Twitter or Linked-In.
MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information
Friday, June 11, 2010
Test Posting of e-newsletter
Stu's Views and MS News
'MS Views and News'is unique in what we do. Bridging the gap to all major MS Organizations.
Providing information and resources from our website, daily via our blog and weekly by our
Study of “Liberation Treatment” to Launch in Buffalo
The University of Buffalo has announced that researchers there, led by the department of neurosurgery, have embarked on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy—dubbed “liberation treatment”—on MS symptoms and progression. Ever since Paolo Zamboni, M.D., of the University of Ferrara, Italy, proposed more than a year ago that a blockage of major venous outflow from the brain and spinal cord in people with MS (a condition known as CCSVI) may be associated with the disease, the MS community has been anxious for further studies to distinguish the role of CCSVI in MS.
PREMiSe (Prospective Randomized Endovascular therapy in Multiple Sclerosis) is a study to determine if endovascular intervention via balloon angioplasty to correct the blockages improves MS symptoms or progression
OUR MISSION: 'MS Views and News' (MSVN) is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis. In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.
_______________________________________________________________________ e-Newsletter Disclaimer:
***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.